<DOC>
	<DOC>NCT01233570</DOC>
	<brief_summary>An assessment of the efficacy of topical tacrolimus in the treatment of cutaneous crohns disease</brief_summary>
	<brief_title>Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>willingness and capability to follow the study procedure confirmed diagnosis of Crohn's Disease of at least 3 months duration confirmed by radiography, endoscopy or pathological examination required to have a skin manifestation of Crohn's disease required to give written informed consent both male and female subjects with reproductive potential required to be on an acceptable form of birth control for the duration of the study longstanding, concomitant immunosuppressive therapy was allowed if the dose was stable and not controlling the skin problem known sensitivity to tacrolimus change in aminosalicylate dosage in the four weeks prior to screening on oral steroids at over 40mg per day been commenced on methotrexate, azathoprine or ciclosporin within the last two months commenced on a a TNFalpha monoclonal antibody within the three months prior to screening patients having had a stoma fashioned less than three months before enrolment patients with an immunocompromising disease patients with a diagnosis of malignancy within the last five years patients with any other condition, past or present treatment thought by the investigator to render the subject ineligible for the study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Cutaneous Crohns Disease</keyword>
	<keyword>Topical Tacrolimus</keyword>
	<keyword>Protopic</keyword>
	<keyword>Metastatic Crohns Disease</keyword>
	<keyword>Pyoderma Gangrenosum</keyword>
	<keyword>Granulomatous chelitis</keyword>
	<keyword>Oral crohns disease</keyword>
	<keyword>Perianal crohns disease</keyword>
</DOC>